Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
09/2005
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572938A2 Polyvalent cation-sensing receptor in atlantic salmon
09/14/2005EP1572937A2 Motif-grafted hybrid polypeptides and uses thereof
09/14/2005EP1572936A2 Heterologous g-csf fusion proteins
09/14/2005EP1572935A2 Methods of making hypermutable cells using pmsr homologs
09/14/2005EP1572934A2 Follistatin domain containing proteins
09/14/2005EP1572933A2 Modulation of immune response by non-peptide binding stress response polypeptides
09/14/2005EP1572931A2 Methods and compositions for modulating and detecting wisp activity
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572929A2 Membrane-anchored beta2 microglobulin covalently linked to mhc class i peptide epitopes
09/14/2005EP1572928A2 Plant acyl-coa synthetases
09/14/2005EP1572927A2 Enhanced silk exsertion under stress
09/14/2005EP1572925A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572924A2 Contraceptive targets
09/14/2005EP1572922A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/14/2005EP1572921A2 Cytokine polypeptides
09/14/2005EP1572920A2 Semisynthetic protein-based site-directed probes for identification and inhibition of active sites, and methods therefor
09/14/2005EP1572918A2 Synthetic glyco-lipo-peptides as vaccines
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572913A2 Methods for the identification of novel ligands for the g protein-coupled receptor (gpcr) 192
09/14/2005EP1572909A2 A follistatin domain containing protein
09/14/2005EP1572908A2 Chimeric molecules for cleavage in a treated host
09/14/2005EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
09/14/2005EP1572906A2 Novel nucleic acid molecules and polypeptides encoding baboon tafi
09/14/2005EP1572905A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572901A2 Transposable elements in rice and methods of use
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572897A2 Ordered biological nanostructures formed from chaperonin polypeptides
09/14/2005EP1572894A2 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid beta, prion protein, amylin, alpha synuclein, or polyglutamine repeats for induction of an immune response thereto
09/14/2005EP1572893A2 Production of adeno-associated virus in insect cells
09/14/2005EP1572892A2 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
09/14/2005EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572883A2 Human cytokine receptor
09/14/2005EP1572882A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof
09/14/2005EP1572881A2 Tacis and br3 polypeptides and uses thereof
09/14/2005EP1572880A2 Defensin polynucleotides and methods of use
09/14/2005EP1572877A2 Drug metabolizing enzymes
09/14/2005EP1572875A2 Receptors and membrane-associated proteins
09/14/2005EP1572873A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins and uses thereof
09/14/2005EP1572872A2 Igs as modifiers of the p53 pathway and methods of use
09/14/2005EP1572871A2 T1r3 a novel taste receptor
09/14/2005EP1572870A2 Molecular sequence of pig endogenous retrovirus receptors and methods of use
09/14/2005EP1572869A2 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
09/14/2005EP1572868A2 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
09/14/2005EP1572867A2 Endothelial cell expression patterns
09/14/2005EP1572866A2 Insect nuclear receptor genes and uses thereof
09/14/2005EP1572865A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/14/2005EP1572864A2 Human serpin polypeptides
09/14/2005EP1572863A2 Method for identifying inhibitors of g protein coupled receptor signaling
09/14/2005EP1572862A2 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
09/14/2005EP1572745A2 Antibody ("11c7") anti nogo a and its pharmaceutical use
09/14/2005EP1572743A2 Peptides and their use for the treatment of hiv infections
09/14/2005EP1572742A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors
09/14/2005EP1572741A1 Therapeutic and diagnostic agents
09/14/2005EP1572740A2 Targeting single epitopes
09/14/2005EP1572739A1 Asthma susceptibility locus
09/14/2005EP1572737A2 Midkine-like protein
09/14/2005EP1572736A2 Thap proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
09/14/2005EP1572735A2 Use of the multifunctional transcription factor yin-yang-1 and variants thereof for treating illnesses, especially type 1 diabetes
09/14/2005EP1572734A1 Peptides impairing pbx dependent gene regulation
09/14/2005EP1572733A1 Inactive transcription factor tif-ia and uses thereof
09/14/2005EP1572732A1 Isolated fluorescent protein from clytia gregaria cgfp and use thereof
09/14/2005EP1572730A2 Nact as a target for lifespan expansion and weight reduction
09/14/2005EP1572729A2 Mutant protein and refolding method
09/14/2005EP1572728A2 Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
09/14/2005EP1572727A1 On-growth inhibiting compounds
09/14/2005EP1572726A2 4-methylhexanoic kahalalide f compound
09/14/2005EP1572724A2 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
09/14/2005EP1572721A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes
09/14/2005EP1572720A2 Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
09/14/2005EP1572719A2 Partial peptide mimetics and methods
09/14/2005EP1572718A2 Alpha nu beta 3 integrin-binding polypeptide monobodies and their use
09/14/2005EP1572717A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/14/2005EP1572714A2 VMP-LIKE SEQUENCES OF PATHOGENIC i BORRELIA /i SPECIES AND STRAINS
09/14/2005EP1572712A2 Cancer-linked gene as target for chemotherapy
09/14/2005EP1572679A2 Crfr1 selective ligands
09/14/2005EP1572345A2 Protein design automation for designing protein libraries with altered immunogenicity
09/14/2005EP1572235A2 Methods of therapy and diagnosis using targeting of cells that express lax
09/14/2005EP1572234A2 STABILIZED IMMUNOGENIC HBc CHIMER PARTICLES
09/14/2005EP1572233A1 Hpv-16 and -18 l1 vlp vaccine
09/14/2005EP1572231A2 Cancer immunotherapy using polycomb proteins
09/14/2005EP1572226A2 Peptides having a high cysteine content
09/14/2005EP1572225A2 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents
09/14/2005EP1572168A2 Anti-infarction molecules
09/14/2005EP1572149A2 Immunogenicity of glucan binding protein
09/14/2005EP1572134A2 Protein s protects the nervous system from injury
09/14/2005EP1572133A2 Method for identifying modulators of human orexin-2 receptor
09/14/2005EP1572130A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572127A2 Enzyme treatment of foodstuffs for celiac sprue
09/14/2005EP1572124A2 Hcv e1e2 vaccine compositions
09/14/2005EP1572121A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
09/14/2005EP1572116A2 Compositions and methods for the treatment of immune related diseases
09/14/2005EP1572111A2 Wound care compositions
09/14/2005EP1572108A2 Functional mutations in respiratory syncytial virus
09/14/2005EP1572104A2 Induction of apoptosis by hiv-1 infected monocytic cells
09/14/2005EP1572099A2 Screening and therapeutic methods relating to neurogenesis
1 ... 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 ... 2916